Arcutis Biotherapeutics, Inc. (ARQT)
24.50
+0.31
(+1.28%)
USD |
NASDAQ |
Apr 17, 15:09
Arcutis Biotherapeutics Research and Development Expense (Quarterly) : 20.45M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| ADMA Biologics, Inc. | 1.376M |
| Axsome Therapeutics, Inc. | 48.68M |
| Arcus Biosciences, Inc. | 121.00M |
| Stoke Therapeutics, Inc. | 41.29M |